Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2019, Article ID 1538439, 10 pages
https://doi.org/10.1155/2019/1538439
Research Article

Elevated Serum IgG Levels Positively Correlated with IL-27 May Indicate Poor Outcome in Patients with HBV-Related Acute-On-Chronic Liver Failure

1Department of Infectious Diseases, The Third Affiliated Hospital of Sun-Yat-sen University, Guangzhou 510630, China
2Guangdong Provincial Key Laboratory of Liver Disease, The Third Affiliated Hospital of Sun-Yat-sen University, Guangzhou 510630, China
3Department of Ultrasound, The Third Affiliated Hospital of Sun-Yat-sen University, Guangzhou 510630, China
4Key Laboratory of Tropical Disease Control (Sun-Yat-sen University), Ministry of Education, Guangzhou 510630, China

Correspondence should be addressed to Ting Zhang; moc.361@41872413631 and Zhi-liang Gao; moc.nc12@oaggnailihz

Received 28 June 2018; Revised 11 October 2018; Accepted 21 April 2019; Published 6 May 2019

Guest Editor: Feng Li

Copyright © 2019 Geng-lin Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Bernal, R. Jalan, A. Quaglia, K. Simpson, J. Wendon, and A. Burroughs, “Acute-on-chronic liver failure,” The Lancet, vol. 386, no. 10003, pp. 1576–1587, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. F. S. Wang and Z. Zhang, “Liver: how can acute-on-chronic liver failure be accurately identified?” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 7, pp. 390-391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. W. K. Seto, C. L. Lai, and M. F. Yuen, “Acute-on-chronic liver failure in chronic hepatitis B,” Journal of Gastroenterology and Hepatology, vol. 27, no. 4, pp. 662–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Jalan, P. Gines, J. C. Olson et al., “Acute-on chronic liver failure,” Journal of Hepatology, vol. 57, no. 6, pp. 1336–1348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Moskophidis, J. Löhler, and F. Lehmann-Grube, “Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection,” Journal of Experimental Medicine, vol. 165, no. 3, pp. 705–719, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Sipeki, P. Antal-Szalmas, P. L. Lakatos, and M. Papp, “Immune dysfunction in cirrhosis,” World Journal of Gastroenterology, vol. 20, no. 10, pp. 2564–2577, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Husby, S. Skrede, J. P. Blomhoff, C. D. Jacobsen, K. Berg, and E. Gjone, “Serum immunoglobulins and organ non-specific antibodies in diseases of the liver,” Scandinavian Journal of Gastroenterology, vol. 12, no. 3, pp. 297–304, 1977. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Martin, D. H. Vroon, and S. M. Nasrallah, “Value of serum immunoglobulins in the diagnosis of liver disease,” Liver, vol. 4, no. 3, pp. 214–218, 1984. View at Google Scholar
  9. H. Iturriaga, T. Pereda, A. Estévez, and G. Ugarte, “Serum immunoglobulin A changes in alcoholic patients,” Annals of Clinical Research, vol. 9, no. 1, pp. 39–43, 1977. View at Google Scholar
  10. A. van de Wiel, J. van Hattum, H. J. Schuurman, and L. Kater, “Immunoglobulin A in the diagnosis of alcoholic liver disease,” Gastroenterology, vol. 94, no. 2, pp. 457–462, 1988. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Hunter and R. Kastelein, “Interleukin-27: balancing protective and pathological immunity,” Immunity, vol. 37, no. 6, pp. 960–969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Iwasaki, K. Fujio, T. Okamura, and K. Yamamoto, “Interleukin-27 in T cell immunity,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 2851–2863, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Boumendjel, L. Tawk, W. Malefijt Rde, V. Boulay, H. Yssel, and J. Pène, “IL-27 induces the production of IgG1 by human B cells,” European Cytokine Network, vol. 17, no. 4, pp. 281–289, 2006. View at Google Scholar
  14. F. Qiu, L. Song, N. Yang, and X. Li, “Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients,” Lupus, vol. 22, no. 10, pp. 1011–1016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. P. Xia, B. F. Li, H. Shen, and J. Lu, “Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis,” Scandinavian Journal of Rheumatology, vol. 44, no. 3, pp. 200–205, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Canale, C. Cocco, C. Frasson et al., “Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model,” Leukemia, vol. 25, no. 12, pp. 1815–1824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Farci, G. Diaz, Z. Chen et al., “B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 19, pp. 8766–8771, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. L. Zhang, D. Y. Xie, Y. N. Ye et al., “High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV,” Liver International, vol. 34, no. 2, pp. 266–273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. G. L. Zhang, D. Y. Xie, B. L. Lin et al., “Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure,” Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 513–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Peng, D. Y. Xie, B. L. Lin et al., “Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes,” Hepatology, vol. 54, no. 3, pp. 820–828, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. L. Zhang, T. Zhang, Q. Y. Zhao, C. S. Lin, and Z. L. Gao, “Th17 cells over 5.9% at admission indicate poor prognosis in patients with HBV-related acute-on-chronic liver failure,” Medicine, vol. 97, no. 40, article e12656, 2018. View at Publisher · View at Google Scholar · View at Scopus
  22. W. R. Kim, S. W. Biggins, W. K. Kremers et al., “Hyponatremia and mortality among patients on the liver-transplant waiting list,” The New England Journal of Medicine, vol. 359, no. 10, pp. 1018–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Jalan, F. Saliba, M. Pavesi et al., “Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure,” Journal of Hepatology, vol. 61, no. 5, pp. 1038–1047, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Sarin and A. Choudhury, “Acute-on-chronic liver failure: terminology, mechanisms and management,” Nature Reviews Gastroenterology & Hepatology, vol. 13, no. 3, pp. 131–149, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. B. Zheng, Z. L. Huang, Z. B. Wu et al., “Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study,” International Journal of Medical Sciences, vol. 10, no. 12, pp. 1658–1664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. McPherson, E. Henderson, A. D. Burt, C. P. Day, and Q. M. Anstee, “Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 60, no. 5, pp. 1055–1062, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Moreau, “The pathogenesis of ACLF: the inflammatory response and immune function,” Seminars in Liver Disease, vol. 36, no. 02, pp. 133–140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Vanwolleghem, J. Hou, G. van Oord et al., “Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells,” Hepatology, vol. 62, no. 1, pp. 87–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Rehermann and M. Nascimbeni, “Immunology of hepatitis B virus and hepatitis C virus infection,” Nature Reviews Immunology, vol. 5, no. 3, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Cocco, F. Morandi, and I. Airoldi, “Interleukin-27 and interleukin-23 modulate human plasmacell functions,” Journal of Leukocyte Biology, vol. 89, no. 5, pp. 729–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Vijayan, N. Mohd Redzwan, D. T. Avery et al., “IL-27 directly enhances germinal center B cell activity and potentiates lupus in Sanroque mice,” The Journal of Immunology, vol. 197, no. 8, pp. 3008–3017, 2016. View at Publisher · View at Google Scholar · View at Scopus